JangoBio

JangoBio says human trials possible next year

By Alex Moe
WisBusiness.com

JangoBio, a biotech company developing a therapy to reduce the negative effects of aging, could be starting human trials as early as next year.

That’s according to company COO Bill Kohl, who spoke alongside CEO Craig Atwood at a recent progress update for interested parties at the Foley & Lardner law offices in Madison.

The company’s proposed method for reducing these effects, including the progression of age-related diseases, involves regrowing key cells in the body that are responsible for keeping hormones in balance. READ FULL STORY

Comments are closed.

Facebook IconYouTube IconTwitter IconVisit Our LinkedIn Profile